Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wisconsin Technology Today.
Press releases published on July 2, 2025

Cycurion Announces a Strategic Partnership with AgileBlue to Deliver Advanced AI-Powered Cybersecurity Operations Across North America
MCLEAN, Va., July 02, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a leading provider of cybersecurity services to public and private sectors, today announced a strategic partnership with AgileBlue, an AI-powered …

XRP News:Limited-Time 8000 XRP Free Reward FINDMINING CEO Announces Major Giveaway for 2025
Atherton, California, July 02, 2025 (GLOBE NEWSWIRE) -- To celebrate FINDMINING’s further expansion into the U.S. and U.K. markets in 2025, FINDMINING is launching a limited-time free reward campaign for XRP enthusiasts worldwide — every registered member …

Genius Group Increases Bitcoin Treasury 20% to 120 Bitcoin; accelerates purchase plan.
SINGAPORE, July 02, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that on July 1, 2025 it increased its Bitcoin Treasury by 20% to …

GDS Announces the Final Offering Price for its C-REIT Initial Public Offering on the Shanghai Stock Exchange
SHANGHAI, China, July 02, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that the final offering …

VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202
BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune- …

BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven
Together, Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven add 30 satellite locations to enroll patients in BriaCell’s pivotal Phase 3 study BriaCell’s Phase 3 study currently has 58 active clinical sites across 15 states, including …

BSTR Miner Launches SOL Cloud Mining Contracts with Unprecedented Demand
New York City, NY, July 02, 2025 (GLOBE NEWSWIRE) -- With SOL prices set to see a major breakout, investors are flocking to leading AI cloud mining platform BSTR Miner as demand for its newly launched SOL mining contracts surges. Market analysts are …

Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
CLEVELAND, July 02, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the closing of the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $155 million on June 27, 2025. Including net …

ZenaTech Expands Drone as a Service (DaaS) to California with Offer to Acquire an Engineering and Surveying Firm, Tapping into Precision Agriculture and Viticulture Market
VANCOUVER, British Columbia, July 02, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), and enterprise SaaS, has …

Invivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID and COVID-19 Post-Vaccination Syndrome
SPEAR Study Group initiated following multiple, independent reports of substantial clinical benefit associated with PEMGARDA® (pemivibart) therapy among people with Long COVID SPEAR Study Group collaborators Drs. Michael Peluso, Amy Proal, and David …

Mozart AI Empowers Music Producers With AI Co-Production
London, July 02, 2025 (GLOBE NEWSWIRE) -- 85% of music today never gets released. London-based Mozart AI has raised $730K in pre-seed funding to solve this problem with the world's first AI-powered Digital Audio Workstation (DAW) that accelerates music …

Dayforce Empowers Canadian Small and Mid-Sized Businesses with Powerpay by Dayforce
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced the rebranding of its payroll and HR solution for Canadian small and mid-sized …

Dayforce offre aux PME canadiennes les moyens de réussir grâce à Powerpay par Dayforce
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE : DAY; TSX : DAY), un chef de file mondial en gestion du capital humain qui améliore la vie au travail, a annoncé aujourd’hui le repositionnement de marque de sa solution de gestion de la paie …

Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
Pelthos plans to launch ZELSUVMI™ for the treatment of Molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, Ligand has invested $18 million in the combined company and is entitled to a 13% royalty on worldwide sales of …

Water Ways Technologies Enters Strategic Partnership for Exclusive Tomato Hybrid Development for Vertical Farming
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Water Ways Technologies Inc. (TSX-V: WWT) (“Water Ways” or the “Company”), a leading provider of advanced agricultural …

Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism
AUSTIN, TX and DURHAM, NC, July 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the …

Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
The combined company plans to launch ZELSUVMI™ for the treatment of molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, the combined company closed on a $50.1 million equity private placement Combined company will …

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models
Combination treatment of mTNX-1700 (mTFF2-MSA fusion protein) with anti-PD1 antibody was associated with increased survival and decreased metastases in animal models of gastric cancer relative to anti-PD1 treatment alone mTNX-1700 treatment was associated …

Crypto Losses Surpass $2.47 Billion in H1 2025, CertiK Report Reveals Alarming Rise in Phishing Attacks
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- CertiK, the world’s largest Web3 security service provider, released its Web3 security quarterly report, Hack3d, for Q2 and H1 2025, revealing that more than $2.47 billion has been lost to hacks, scams, and …

CertiK, ‘Hack3d’ 보안 보고서 발표: 2025년 상반기 손실액 작년 연간치 넘어…피싱 공격이 주요 원인
뉴욕, July 02, 2025 (GLOBE NEWSWIRE) -- 글로벌 최대 Web3 보안 기업 CertiK이 최신 ‘Hack3d: 2025년 2분기 및 상반기 Web3 보안 보고서’를 발표했다. 보고서에 따르면 2025년 상반기 발생한 보안 사고로 인한 손실액은 약 25억 달러에 달하며, 이는 이미 작년 한 해 전체 손실액을 넘어선 수치다. 전반적으로 Web3 보안 상황은 여전히 심각하며, 공격 방식 또한 지속적으로 진화하고 있다. 보고서에 따르면, …